Medical Condition

cardiogenic shock

Total Trials

12

Recruiting Now

12

Trial Phases

Phase 4, EARLY_Phase 1

ClinicalMetric tracks all active clinical trials for cardiogenic shock sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — cardiogenic shock Clinical Trials

How many clinical trials are currently recruiting for cardiogenic shock?

ClinicalMetric currently tracks 12 actively recruiting clinical trials for cardiogenic shock, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 12. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.

What trial phases are available for cardiogenic shock?

cardiogenic shock research spans Phase 1 (1 trial), Phase 4 (2 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.

How do I find out if I qualify for a cardiogenic shock clinical trial?

Eligibility criteria for cardiogenic shock trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.

Trial Phases

Phase 1

Phase 4

Top Sponsors

Samsung Medical Center 2 trials

China National Center for Cardiovascular Diseases 1 trial

Institute for Clinical and Experimental Medicine 1 trial

University of Chicago 1 trial

Fondazione Don Carlo Gnocchi ETS 1 trial

Recruiting Clinical Trials

NCT07769528

Recruiting

Safety and Efficacy of the Extracorporeal Ventricular Assist System in Car Diogenic Shock: A Prospective, Multicenter , Single-Arm Study

China National Center for Card...

View Trial →

NCT07527156 Phase 4

Recruiting

Prolonged Nasogastric Administration of Ketones in Decompensated Heart Failure

Institute for Clinical and Exp...

View Trial →

NCT05700617 EARLY_Phase 1

Recruiting

Cardiac Power Output in Cardiogenic Shock Patients

University of Chicago

View Trial →

NCT06572826

Recruiting

Cardiac Rehabilitation in Patients Acutely Managed for Cardiogenic Shock (ENIGMA)

Fondazione Don Carlo Gnocchi E...

View Trial →

NCT06965504

Recruiting

INitiation and Titration of Guideline Directed Medical TheRApy in HearT Failure Cardiogenic Shock With ImpElla 5.5 for Cardiac Recovery

Factors Influencing Outcomes in ECMO and Impella Patients: Metabolic and Thyroid Hormone Dynamics

Gottsegen National Cardiovascu...

View Trial →

NCT05527717 Phase 4

Recruiting

Revascularization Strategy of Multivessel Disease for Patients with Acute Myocardial Infarction Complicated by Cardiogenic Shock Undergoing Veno-arterial Extracorporeal Membrane Oxygenator

Samsung Medical Center

View Trial →

NCT05366452

Recruiting

Evaluation of the Efficacy of Early Implantation of a Percutaneous Left Ventricular Assist Devices in Acute Coronary Syndrome Complicated by Cardiogenic Shock Compared to Conventional Therapy: a Prospective, Multicenter, Randomized, Controlled and Open-label Clinical Trial

Assistance Publique Hopitaux D...

View Trial →

NCT04682483

Recruiting

Cardiogenic Shock Working Group Registry

Post-Surgery Extracorporeal Life Support

University of Florence

View Trial →

NCT07482865

Recruiting

Routine Versus Provisional Distal Perfusion Catheter Placement in Patients Undergoing Mechanical Circulatory Support

Samsung Medical Center

View Trial →

NCT03378739

Recruiting

Inova Cardiogenic Shock Registry (INOVA SHOCK)

Inova Health Care Services

View Trial →

Related Conditions

heart failure (3) acute heart failure ahf (1) ketones (1) ketone body metabolism (1) reduced ejection fraction heart failure (1) euthyroid sick syndrome (1) critical illness (1) acute myocardial infarction (1) multi vessel coronary artery disease (1) extracorporeal membrane oxygenation (1) extracorporeal life support (1) extracorporeal membrane oxygenation complication (1)

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology